AdvisorShares Investments’s Clearmind Medicine CMND Stock Holding History

AdvisorShares Investments’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57K	Buy	146 +54	+59%	+$2.46K	﹤0.01%	265
2026 Q1	$7.65K	Buy	92 +9	+11%	+$1.11K	﹤0.01%	276
2025 Q4	$12K	Buy	83 +13	+19%	+$20.7K	﹤0.01%	288
2025 Q3	$230K	Buy	70 +6	+9%	+$19.6K	0.04%	220
2025 Q2	$182K	Sell	64 -5	-7%	-$15.4K	0.03%	223
2025 Q1	$228K	Buy	69 +17	+33%	+$70.9K	0.04%	214
2024 Q4	$232K	Sell	52 -1	-2%	-$4.43K	0.04%	217
2024 Q3	$208K	Buy	53 +13	+33%	+$59.2K	0.04%	216
2024 Q2	$214K	Buy	40 +5	+14%	+$19.3K	0.04%	221
2024 Q1	$128K	Buy	35 +6	+21%	+$29.4K	0.02%	253
2023 Q4	$260K	Buy	29 +28	+2,800%	+$352K	0.06%	221
2023 Q3	$19.7K	Hold	1	–	–	0.01%	235
2023 Q2	$57.9K	Sell	1 -1	-50%	-$54K	0.02%	242
2023 Q1	$176K	Buy	+2	New	+$667K	0.06%	200

Other funds holding CMND

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

AdvisorShares Investments's CMND Position: Q2 2026 in Review

AdvisorShares Investments increased its Clearmind Medicine (CMND) stake by 59% in Q2 2026, buying an estimated $2.46K and bringing the position to 146 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #265.

AdvisorShares Investments first reported a position in CMND in Q1 2023 and has held it in 14 quarters since. The position peaked at $260K in Q4 2023. 5 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

AdvisorShares Investments held 146 shares of Clearmind Medicine worth $2.57K as of Q2 2026.
AdvisorShares Investments bought 54 Clearmind Medicine shares in Q2 2026, an estimated $2.46K.
Clearmind Medicine made up ﹤0.01% of AdvisorShares Investments's portfolio in Q2 2026, its #265 holding.
AdvisorShares Investments first reported a position in Clearmind Medicine in Q1 2023 and has held it in 14 quarters since.
AdvisorShares Investments's Clearmind Medicine position peaked at $260K in Q4 2023.
5 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.